OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,277,264 | -2.6% | 2,085,179 | -31.8% | 0.01% | 0.0% |
| Q4 2022 | $7,468,478 | -20.4% | 3,057,306 | -55.0% | 0.01% | -28.6% |
| Q3 2022 | $9,379,370 | -30.7% | 6,793,374 | +104.5% | 0.01% | -22.2% |
| Q2 2022 | $13,531,000 | -10.7% | 3,321,133 | -6.6% | 0.01% | +28.6% |
| Q1 2022 | $15,145,000 | -46.0% | 3,557,434 | +18.8% | 0.01% | -41.7% |
| Q4 2021 | $28,033,000 | -58.9% | 2,995,440 | +21.0% | 0.01% | -60.0% |
| Q3 2021 | $68,216,000 | -24.4% | 2,475,830 | -23.2% | 0.03% | -23.1% |
| Q2 2021 | $90,252,000 | -20.7% | 3,224,678 | -9.8% | 0.04% | -25.0% |
| Q1 2021 | $113,795,000 | -29.3% | 3,575,568 | -1.7% | 0.05% | -30.7% |
| Q4 2020 | $160,929,000 | – | 3,638,838 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |